Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising https://deannaqwhd046196.affiliatblogger.com/91108414/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements